NYSEEnergyOil & Gas Equipment & ServicesS&P SmallCap 600
$25.13
+0.70 (+2.87%)
Close of Nov 06, 2026 · end-of-day data
INVX 8-K filings, explained
Every material Form 8-K Innovex International has filed with the SEC since February 25, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Innovex International reported third-quarter 2026 revenue of $265 million, up 10% from a year earlier, and Adjusted EBITDA of $55 million, up from $44 million. Net income fell to $26 million from $39 million a year earlier, and diluted EPS was $0.37 versus $0.57, so shareholders see higher sales alongside lower GAAP profit. The company also guided fourth-quarter 2026 revenue to $260 million to $270 million and Adjusted EBITDA to $53 million to $58 million.
Q3 2026 revenue was $265 million, up 8% from Q2 2026 and up 10% from Q3 2025.
Net income was $26 million versus $39 million in Q3 2025; diluted EPS was $0.37 versus $0.57.
Income from operations was $32 million, down from $62 million a year earlier.
Q4 2026 guidance: revenue of $260 million to $270 million and Adjusted EBITDA of $53 million to $58 million.
Innovex International entered an underwriting agreement with Amberjack Capital Partners affiliates and Barclays Capital for the sale of 5,000,000 common shares by the selling stockholders. The company sold no shares and received no proceeds, so the offering does not add new shares or cash to the company.
Selling stockholders are affiliates of Amberjack Capital Partners, L.P.; the company received no proceeds
5,000,000 shares offered at a price to the underwriter of $28.71 per share
Underwriting agreement dated August 6, 2026; offering closed August 10, 2026
Offering made under an effective Form S-3 shelf registration (File No. 333-282178)
Innovex reported second-quarter 2026 revenue of $245 million, up 9% from a year earlier, and net income of $25 million, or $0.36 per diluted share, after a net loss in the first quarter tied to a $48.8 million legal settlement provision. The company also gave third-quarter guidance of $260 to $270 million in revenue and $51 to $57 million in Adjusted EBITDA, which includes TCO, a business it acquired on July 1, 2026 for $95 million in cash and stock.
Q2 2026 revenue was $244.9 million, up 2% from Q1 2026 and up 9% from Q2 2025.
Net income was $25.0 million ($0.36 per diluted share), compared with a net loss of $16.7 million in Q1 2026 and net income of $15.3 million in Q2 2025.
Adjusted EBITDA was $48.0 million, down from $49.3 million in Q1 2026 and up from $46.6 million in Q2 2025.
Cash and cash equivalents were $222 million at June 30, 2026, with no bank debt; free cash flow was $30.4 million.
Innovex reported first-quarter 2026 revenue of $239.0 million, down 13% from the prior quarter and 1% from a year earlier, and a GAAP net loss of $16.7 million, compared with net income of $14.8 million a year earlier. The loss reflects a $48.8 million provision for a legal settlement tied to the Impulse Litigation, while non-GAAP Adjusted EBITDA rose to $49.3 million, and the company guided second-quarter 2026 Adjusted EBITDA to $43 million to $48 million.
Revenue of $239.0 million, down from $273.6 million in the fourth quarter of 2025 and $240.4 million in the first quarter of 2025
Net loss of $16.7 million, or $0.24 per share, including a $48.8 million provision for legal settlement, versus net income of $14.8 million, or $0.21 per share, a year earlier
Adjusted EBITDA (non-GAAP) of $49.3 million with a 21% margin, compared with $45.9 million and 19% a year earlier
Second-quarter 2026 guidance: revenue of $235 million to $245 million and Adjusted EBITDA of $43 million to $48 million
Innovex International entered a February 25, 2026 underwriting agreement under which affiliates of Amberjack Capital Partners sold 5,750,000 shares at $25.75 each, and the underwriters later exercised their option in full for 862,500 more. Innovex sold no shares and received no offering proceeds, but it bought 575,000 shares from the underwriters for about $14.1 million under its existing buyback program, leaving about $76.6 million remaining under that program.
Selling stockholders sold 5,750,000 shares at $25.75 per share; underwriters exercised a 30-day option for 862,500 additional shares on February 26, 2026
Innovex did not sell any shares and received no proceeds from the offering
Innovex repurchased 575,000 shares for approximately $14.1 million; about $76.6 million remains under the buyback program
Offering and share repurchase closed on February 27, 2026
Innovex reported fourth-quarter 2025 revenue of $274 million, up 14% from the prior quarter, but net income fell to $14 million from $39 million in the third quarter and $32 million a year earlier. The company guided first-quarter 2026 revenue to $225 million to $235 million and Adjusted EBITDA to $38 million to $42 million, both below its fourth-quarter results, citing lower subsea deliveries and seasonality.
Q4 2025 revenue of $274 million, up from $240 million in Q3 2025 and $251 million in Q4 2024
Q4 2025 net income of $14 million (5% margin) and diluted EPS of $0.20, versus $0.57 in Q3 2025
Q4 2025 Adjusted EBITDA of $52 million (19% margin); full-year 2025 free cash flow of $156 million
Q1 2026 guidance: revenue of $225 million to $235 million and Adjusted EBITDA of $38 million to $42 million
Innovex International director Carri Lockhart, who chairs the Nominating and Governance Committee and sits on the Audit Committee, notified the board on November 5, 2025 that she will resign effective March 2, 2026. The filing states the decision did not arise from any disagreement with the company on operations, policies or practices.
Carri Lockhart notified the board of her resignation on November 5, 2025, effective March 2, 2026.
She chairs the Nominating and Governance Committee and is a member of the Audit Committee.
The company states the resignation did not result from any disagreement on operations, policies or practices.
Innovex International reported third-quarter 2025 revenue of $240 million, up 7% from $224.2 million in the prior quarter, and net income of $39.2 million, up from $15.3 million. Net income included a $40.9 million gain on sale of assets, and Adjusted EBITDA fell to $43.6 million from $46.6 million as margin declined to 18% from 21%. The company guided fourth-quarter revenue to $235 million to $245 million and Adjusted EBITDA to $42 million to $47 million.
Q3 2025 revenue $240.0 million vs. $224.2 million in Q2 2025 and $151.8 million in Q3 2024
Net income $39.2 million, or $0.57 per diluted share, vs. $0.22 per diluted share in Q2 2025; Q3 2024 net income was $82.6 million
Adjusted EBITDA $43.6 million, margin 18%, vs. $46.6 million and 21% in Q2 2025; company cites Eldridge facility relocation costs
Q4 2025 guidance: revenue $235 million to $245 million; Adjusted EBITDA $42 million to $47 million
Innovex reported second-quarter 2025 revenue of $224 million, down 7% from the prior quarter, and net income of $15 million. The company guided to third-quarter 2025 revenue of $230-$240 million and Adjusted EBITDA of $40-$45 million, and said it closed the $70 million all-cash Citadel Casing Solutions acquisition on May 30.
Q2 2025 revenue of $224 million, down 7% quarter over quarter; net income of $15 million
Q2 operating cash flow of $59 million and free cash flow of $52 million
Q3 2025 guidance: total revenue of $230-$240 million and Adjusted EBITDA of $40-$45 million
Citadel acquisition closed May 30 for $70 million in cash; Eldridge facility sale targeted to close in Q3 2025
Innovex International's board approved new forms of restricted stock unit and performance unit award agreements under its 2025 Long-Term Incentive Plan, and the agreements were used to grant awards to CEO Adam Anderson, CFO Kendal Reed and President of North America Mark Reddout. The awards tie executive pay to multi-year vesting, total shareholder return and return on capital employed, and set out severance and change-in-control terms.
Board approved the award agreements on May 30, 2025.
CEO Adam Anderson received 68,073 RSUs and 68,073 performance units; CFO Kendal Reed and Mark Reddout each received 25,527 of each.
RSUs vest in three equal annual installments on April 4, 2026, 2027 and 2028.
Performance units can be earned between 0% and 200% of target over a three-year period ending December 31, 2027.
At its May 14, 2025 annual meeting, Innovex International, Inc. stockholders approved a 2025 Long-Term Incentive Plan, an amendment doubling authorized common stock from 100,000,000 to 200,000,000 shares, and the election of three directors. Stockholders also ratified PricewaterhouseCoopers LLP as auditor and approved executive compensation in an advisory vote. The authorized share increase and the plan's up to 5,000,000 new shares could lead to future dilution of existing holdings.
Authorized common stock rises from 100,000,000 to 200,000,000 shares, effective May 14, 2025 upon filing with Delaware.
2025 LTIP provides for issuance of up to 5,000,000 shares of common stock and was approved with 56,201,765 votes for and 5,933,901 against.
Terence Jupp, Carri Lockhart and Jason Turowsky elected to three-year terms expiring at the 2028 annual meeting.
PricewaterhouseCoopers LLP ratified as auditor for the year ending December 31, 2025, with 64,939,170 votes for.
Innovex reported first-quarter 2025 revenue of $240 million, down 4% from the prior quarter, with net income of $15 million and Adjusted EBITDA of $46 million. For the second quarter, the company guided to revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million, both below first-quarter levels, citing softness in Mexico and slight activity declines in the North American land market.
Q1 2025 revenue of $240 million, down 4% quarter over quarter; net income of $15 million; Adjusted EBITDA of $46 million
Q2 2025 guidance: total revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million
Agreed to sell the legacy Dril-Quip Eldridge facility for $95 million; the company also has a $100 million share repurchase program
As of May 5, 2025, repurchased 395,234 shares at an average price of $14.94
Innovex International agreed on April 21, 2025 to sell its Eldridge facility in Houston to BIG Acquisitions LLC for $95.0 million, subject to adjustments, with a short-term lease back to the company and closing expected in the third quarter of 2025. In a same-day update, the company said first-quarter 2025 revenue is expected to be about $240 million, below its previous guidance of $245 million to $255 million, while Adjusted EBITDA is expected to be $44 million to $46 million.
Eldridge facility sale price is $95.0 million, subject to adjustments; closing expected in Q3 2025
Short-term lease back from the buyer runs to December 31, 2025, with one six-month extension option and gross rent of $650,000 per month
Preliminary Q1 2025 revenue of about $240 million vs. prior guidance of $245 million to $255 million; Adjusted EBITDA $44 million to $46 million
Q1 2025 earnings release set for May 6, 2025; conference call on May 7, 2025
Innovex International appointed Will Donnell as a Class II director effective March 3, 2025, filling a seat left vacant after the passing of Patrick Connelly. Donnell will receive the standard non-employee director annual fee of $75,000 and signed an indemnification agreement with the company.
Will Donnell appointed Class II director effective March 3, 2025, to fill vacancy from Patrick Connelly's passing
Annual non-employee director fee of $75,000
Indemnification agreement entered into March 4, 2025, covering expenses under Delaware law
Donnell is not related to any officer or director; no arrangement with others other than the existing Stockholder's Agreement with Amberjack Capital Partners
Innovex reported fourth-quarter 2024 revenue of $251 million, up 89% year-over-year, and adjusted EBITDA of about $49 million, up $17 million from a year earlier, with the Dril-Quip merger and DWS acquisition driving the gains. The board authorized a $100 million share repurchase program, and the company guided first-quarter 2025 adjusted EBITDA to $45 million to $50 million and revenue to $245 million to $255 million.
Q4 2024 revenue was $251 million, up 89% year-over-year and 65% sequentially; full-year 2024 revenue was $661 million, up 19%.
Q4 2024 adjusted EBITDA was about $49 million; free cash flow was $29 million.
Board authorized a $100 million share repurchase program.
Q1 2025 guidance: adjusted EBITDA of $45 million to $50 million and revenue of $245 million to $255 million.
Innovex International reported fourth-quarter 2024 revenue of $251 million, up from $152 million in the third quarter and $133 million a year earlier, and net income of $32 million, compared with $18 million a year earlier. The company also gave first-quarter 2025 revenue guidance of $245 million to $255 million and Adjusted EBITDA guidance of $45 million to $50 million, and its board approved a new $100 million share repurchase program.
Q4 2024 revenue of $251 million, up 65% from Q3 2024 and up from $133 million in Q4 2023; full-year 2024 revenue was $661 million
Q4 2024 net income of $32 million, down from $83 million in Q3 2024 but up from $18 million in Q4 2023; full-year net income was $140 million
Q1 2025 guidance: total revenue of $245 million to $255 million and Adjusted EBITDA of $45 million to $50 million
Board approved a new share repurchase program of up to $100 million on February 25, 2025, replacing prior Dril-Quip plans
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Innovex International filing is on SEC EDGAR ↗. 8-K briefs of other companies →